Produktbild: Practical Manual for Dermatologic and Surgical Melanoma Management

Practical Manual for Dermatologic and Surgical Melanoma Management

49,99 €

inkl. gesetzl. MwSt., Versandkostenfrei


Beschreibung

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

12.05.2020

Abbildungen

V, 50 illus., 49 illus. in color., schwarz-weiss Illustrationen, farbige Illustrationen

Herausgeber

Delphine J. Lee + weitere

Verlag

Springer

Seitenzahl

196

Maße (L/B/H)

23,5/15,5/1,1 cm

Gewicht

355 g

Auflage

1st ed. 2021

Sprache

Englisch

ISBN

978-3-030-27399-6

Beschreibung

Portrait

Dr. Delphine J. Lee is the Chief of Dermatology and Residency Program Director at Harbor-UCLA Medical Center located in the South Bay.  She received her MD and PhD at University of California, San Diego and completed her dermatology residency training and postdoctoral fellowship at University of California, Los Angeles.  After serving on the faculty at UCLA for five years, she moved to build the Department of Translational Immunology at John Wayne Cancer Institute where her team developed studies utilizing bioinformatic approaches combined with immune studies to gain new insights into melanoma.  She currently conducts translational studies on host-microbe associations and interactions in melanoma and other cancers at Los Angeles Biomedical Research Institute and serves as chair and standing member of the NIAMS AMS review committee.

  

Dr. Mark Faries is the Co-Director of the Melanoma Program at the Angeles Clinic and Research Institute and Head of the Surgical Oncology Division. He received his medical degree from Cornell University and completed surgical residency at the University of Pennsylvania. His Fellowship in surgical oncology was at the John Wayne Cancer Institute where he trained under Donald L. Morton. He conducts clinical and translational research in melanoma and immunotherapy and is the Principal Investigator of the Multicenter Selective Lymphadenectomy (II) Trial. He serves on the Editorial Board of of the  Annals of Surgical Oncology  and is a member of the American Joint Committee on Cancer’s Melanoma Staging Committee.

 

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

12.05.2020

Abbildungen

V, 50 illus., 49 illus. in color., schwarz-weiss Illustrationen, farbige Illustrationen

Herausgeber

Verlag

Springer

Seitenzahl

196

Maße (L/B/H)

23,5/15,5/1,1 cm

Gewicht

355 g

Auflage

1st ed. 2021

Sprache

Englisch

ISBN

978-3-030-27399-6

Herstelleradresse

Springer-Verlag GmbH
Tiergartenstr. 17
69121 Heidelberg
DE

Email: ProductSafety@springernature.com

Kundinnen und Kunden meinen

0 Bewertungen

Informationen zu Bewertungen

Zur Abgabe einer Bewertung ist eine Anmeldung im Konto notwendig. Die Authentizität der Bewertungen wird von uns nicht überprüft. Wir behalten uns vor, Bewertungstexte, die unseren Richtlinien widersprechen, entsprechend zu kürzen oder zu löschen.

Die Bewertungen sind nach Format, Anzahl Sterne und Datum sortiert.

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kund*innen durch Ihre Meinung

Kundinnen und Kunden meinen

0 Bewertungen filtern

  • Produktbild: Practical Manual for Dermatologic and Surgical Melanoma Management
  • Melanoma Prevention.- Prevention.- Screening.- Racial disparities/melanoma in non-whites with guidelines for all races on screening,-Monitoring (people at-risk, people who have had melanoma-follow up, genetic syndromes, atypical Nevus syndrome), -Primary Melanoma.- Diagnosis.-  Prognosis (staging).- Pediatric Melanoma/Spitz Nevi.- Ocular Melanoma.- Mucosal Melanoma.- Treatment of Primary Melanoma.- Mohs Micrographic surgery LMM; role for Immunohistochemistry.- Early stage disease in patients who are not surgical candidates.- Staging (surgeon)/Surgical treatment /Sentinel LN biopsy - when to perform, management of +SLNB.- Adjuvant therapy.- Treatment of Regionally Metastatic Melanoma.- Local therapies for local recurrence (Emanuel) local recurrence/intransit mets.- Management of the positive sentinel Lymph Node.- Radiation therapy.- Metastatic disease.- Targeted therapy (including a section on personalized therapy/genomics).- Immunotherapy (including a section on personalized immune therapies).- Neoadjuvant therapy.- Stage IV surgical management, including M1A, M1B, M1C disease.- Brain metastases.